VIMTA LABS
Back to Cashflow Statement
|
VIMTA LABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.90 Cr | ₹-11 Cr | ₹-17 Cr | ₹-4.57 Cr | ₹-0.67 Cr |
What is the latest Cash Flow from Financing Activities ratio of VIMTA LABS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2024 | ₹-1.90 Cr |
| Mar2023 | ₹-11 Cr |
| Mar2022 | ₹-17 Cr |
| Mar2021 | ₹-4.57 Cr |
| Mar2020 | ₹-0.67 Cr |
How is Cash Flow from Financing Activities of VIMTA LABS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2024 | ₹-1.90 Cr | Negative | |
| Mar2023 | ₹-11 Cr | Negative | |
| Mar2022 | ₹-17 Cr | Negative | |
| Mar2021 | ₹-4.57 Cr | Negative | |
| Mar2020 | ₹-0.67 Cr | - | |
Compare Cash Flow from Financing Activities of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹1,873.2 Cr | -3.4% | -14.7% | -8.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,000.0 Cr | -0.4% | 5.3% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,076.0 Cr | -4.3% | -6.3% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,510.0 Cr | 0.4% | 8.2% | 44.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,921.0 Cr | 0.5% | 1.8% | 16.4% | Stock Analytics | |
| CIPLA | ₹106,150.0 Cr | -0.8% | -2.6% | -9.2% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | -3.4% |
-14.7% |
-8.1% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses